December 2022

IBMS research grants 2022

The four recipients of IBMS research grants in 2022 explain their projects and the impact they hope their work will have.

Navigating diagnostics: Will testing leave the lab and move to the community

On the back of a new report on the future of diagnostics, we look at whether lab services are likely to be moved out into the community.

Artificial enzymes programmed to destroy SARS-CoV-2

Cambridge scientists have used synthetic biology to create artificial enzymes programmed to target the genetic code of SARS-CoV-2 and destroy the virus.

Genes identified to potentially diagnose Lyme disease

Researchers at the Icahn School of Medicine at Mount Sinai in New York have identified 35 genes that are particularly highly expressed in people with long-term Lyme disease.

The big question: The biomedical science workforce

This month we ask “How can we solve the workforce shortage in biomedical science?”

How stealthy HIV evades drugs and immunity

An immune response that likely evolved to help fight infections appears to be the mechanism that drives human immunodeficiency virus (HIV) into a latent state, researchers at Duke Health in the US report.

Pushing back the frontiers with "click chemistry"

Ben Schumann discusses his work and the potential to understand the complex molecular and cellular processes at work in diseases.

Tech news: December 2022

This month's top tech news stories

Bone marrow organoids

Scientists from the University of Oxford and the University of Birmingham have made the first bone marrow “organoids” that capture the key features of human bone marrow.

Novel device to measure nerve activity

A research team has developed a novel device for non-invasively measuring cervical nerve activity in humans.

Top